- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
HOOKIPA Pharma (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma (NASDAQ: HOOK)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.240 | -0.400 | -0.1600 | ||||
| REV | 14.530M | 1.445M | -13.085M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
HOOKIPA Pharma Questions & Answers
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Alzamend Neuro (NASDAQ:ALZN), Anixa Biosciences (NASDAQ:ANIX), Fortress Biotech (NASDAQ:FBIO), Galectin Therapeutics (NASDAQ:GALT) and Curis (NASDAQ:CRIS).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by RBC Capital on Friday, March 25, 2022. The analyst firm set a price target for 9.00 expecting HOOK to rise to within 12 months (a possible 435.71% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $1.68 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for HOOKIPA Pharma.
HOOKIPA Pharma’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.